National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 43417 [2024-10886]
Download as PDF
Federal Register / Vol. 89, No. 97 / Friday, May 17, 2024 / Notices
Dated: May 14, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–10873 Filed 5–16–24; 8:45 am]
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Clinical Trials SEP (R61).
Date: June 27, 2024.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 205–J,
Bethesda, MD 20892, (301) 827–7085,
zhihong.shan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 14, 2024.
Patricia B. Hansberger,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–10874 Filed 5–16–24; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; CARE–T1D
Consortium.
Date: June 20, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Lan Tian, Ph.D., Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, 6707
Democracy Boulevard, Bethesda, MD 20892,
Bethesda, MD 20892–2542, tianl@
niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: May 14, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–10886 Filed 5–16–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Notice Regarding the Uyghur Forced
Labor Prevention Act Entity List
Department of Homeland
Security.
ACTION: Notice.
AGENCY:
The U.S. Department of
Homeland Security (DHS), as the Chair
SUMMARY:
VerDate Sep<11>2014
17:20 May 16, 2024
Jkt 262001
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
43417
of the Forced Labor Enforcement Task
Force (FLETF), announces the
publication and availability of the
updated Uyghur Forced Labor
Prevention Act (UFLPA) Entity List, a
consolidated register of the four lists
required to be developed and
maintained pursuant to section
2(d)(2)(B) of the UFLPA, on the DHS
UFLPA website. The updated UFLPA
Entity List is also published as an
appendix to this notice. This update
adds twenty-six entities to the section
2(d)(2)(B)(v) list of the UFLPA, which
identifies facilities and entities that
source material from Xinjiang Uyghur
Autonomous Region or from persons
working with the government of
Xinjiang or the Xinjiang Production and
Construction Corps for purposes of the
‘‘poverty alleviation’’ program or the
‘‘pairing-assistance’’ program or any
other government labor scheme that
uses forced labor. Details related to the
process for revising the UFLPA Entity
List are included in this Federal
Register notice.
DATES: This notice announces the
publication and availability of the
UFLPA Entity List updated as of May
17, 2024, included as an appendix to
this notice.
ADDRESSES: Persons seeking additional
information on the UFLPA Entity List
should email the FLETF at
FLETF.UFLPA.EntityList@hq.dhs.gov.
FOR FURTHER INFORMATION CONTACT:
LeRoy Potts, Director, Entity List Office,
Trade and Economic Security, Office of
Strategy, Policy, and Plans, DHS. Phone:
(202) 891–2331, Email:
FLETF.UFLPA.EntityList@hq.dhs.gov.
SUPPLEMENTARY INFORMATION: The U.S.
Department of Homeland Security
(DHS), on behalf of the Forced Labor
Enforcement Task Force (FLETF), is
announcing the publication of the
updated UFLPA Entity List, a
consolidated register of the four lists
required to be developed and
maintained pursuant to section
2(d)(2)(B) of the Uyghur Forced Labor
Prevention Act (Pub. L. 117–78)
(UFLPA), to https://www.dhs.gov/uflpaentity-list. The UFLPA Entity List is
available as an appendix to this notice.
This update adds twenty-six entities to
the section 2(d)(2)(B)(v) list of the
UFLPA, which identifies facilities and
entities that source material from
Xinjiang Uyghur Autonomous Region or
from persons working with the
government of Xinjiang or the Xinjiang
Production and Construction Corps for
purposes of the ‘‘poverty alleviation’’
program or the ‘‘pairing-assistance’’
program or any other government labor
scheme that uses forced labor. Future
E:\FR\FM\17MYN1.SGM
17MYN1
Agencies
[Federal Register Volume 89, Number 97 (Friday, May 17, 2024)]
[Notices]
[Page 43417]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-10886]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; CARE-T1D Consortium.
Date: June 20, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, NIDDK, Democracy II, Suite
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Lan Tian, Ph.D., Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, 6707
Democracy Boulevard, Bethesda, MD 20892, Bethesda, MD 20892-2542,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: May 14, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-10886 Filed 5-16-24; 8:45 am]
BILLING CODE 4140-01-P